Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • Our Impact
    • Why CIFAR?
    • Impact Clusters
    • News
    • CIFAR Strategy
    • Nurturing a Resilient Earth
    • AI Impact
    • Donor Impact
    • CIFAR 40
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
    • Staff Directory
  • Support Us
  • About
    • Our Story
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
    • Statement on Institutional Neutrality
    • Research Security
  • fr
  • Home
  • Bio

Follow Us

Ferdia-Gallagher_bw

Ferdia Gallagher

Appointment

Fellow

CIFAR MacMillan Multiscale Human

Connect

Website

About

My group develops novel in vivo molecular imaging methods to probe tissue biology non-invasively using MRI and PET. In particular, we have used multinuclear MRI approaches to study cellular biology at a whole organism level and have correlated the imaging results with tissue acquired at biopsy and at surgery. For example, our group has pioneered the use of hyperpolarised carbon-13 MRI as an emerging method to probe tissue metabolism, and more recently we have developed deuterium metabolic imaging at clinical field strength. We are particularly interested in studying how tissue biomarkers of disease can inform on the underlying biological drivers of non-invasive imaging. By combining tissue and imaging based biomarkers, we aim to use these for early cancer detection, to improve disease stratification based on tumour aggressiveness, and to detect successful response to treatment earlier.

Awards

  • Honorary Skou Professor, University of Aarhus, 2022
  • New Technologies Award, The British Institute of Radiology, 2022
  • Magnetic Resonance Imaging Prize for outstanding achievements in the field of MRI
  • Garmisch-Partenkirchen MRI Symposium, 2021
  • Emerging Leaders Club, International Society for Strategic Studies in Radiology, 2022
  • Adjunct Professor, Medical University of Vienna, 2019-22

Relevant Publications

  • Sushentsev N, McLean MA, Warren AY, Benjamin AJ, Brodie C, Frary A, Gill AB, Jones J, Kaggie JD, Lamb BW, Locke MJ, Miller JL, Mills IG, Priest AN, Robb FJ, Shah N, Schulte RS, Graves MJ, Gnanapragasam VJ, Brindle KM, Barrett T, Gallagher FA (2022). Hyperpolarised 13C-MRI visualises metabolism in the tumour epithelium and the emergence of a glycolytic cell population within intermediate-risk human prostate cancer. Nat Commun. Jan 24;13(1):466. doi: 10.1038/s41467-022-28069-2
  • Woitek R, McLean MA, Ursprung S, Rueda OM, Manzano Garcia R, Locke MJ, Beer L, Baxter G, Rundo L, Provenzano E, Kaggie J, Patterson A, Frary A, Field-Rayner J, Papalouka V, Kane J, Benjamin AJV, Gill AB, Priest AN, Lewis DY, Russell R, Grimmer A, White B, Latimer-Bowman B, Patterson I, Schiller A, Carmo B, Slough R, Lanz T, Wason J, Schulte RF, Chin SF, Graves MJ, Gilbert FJ, Abraham JE, Caldas C, Brindle KM, Sala E, Gallagher FA. (2021) Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer Res. Dec 1;81(23):6004-6017. doi: 10.1158/0008-5472.CAN-21-1499
  • Lau D, McLean MA, Priest AN, Gill AB, Scott F, Patterson I, Carmo B, Riemer F, Kaggie JD, Frary A, Milne D, Booth C, Lewis A, Sulikowski M, Brown L, Lapointe JM, Aloj L, Graves MJ, Brindle KM, Corrie PG, Gallagher FA. (2021) Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma. J Immunother Cancer. Sep;9(9):e003125. doi: 10.1136/jitc-2021-003125

Institution

University of Cambridge

Department

Department of Radiology

Education

  • FRCP (Medicine), Royal College of Physicians
  • FRCR (Radiology), Royal College of Radiologists
  • PhD (Biochemistry), University of Cambridge BM BCh (Medicine), University of Oxford
  • BA (Physiology), University of Cambridge

Country

United Kingdom

Support Us

The Canadian Institute for Advanced Research (CIFAR) is a globally influential research organization proudly based in Canada. We mobilize the world’s most brilliant people across disciplines and at all career stages to advance transformative knowledge and solve humanity’s biggest problems, together. We are supported by the governments of Canada, Alberta and Québec, as well as Canadian and international foundations, individuals, corporations and partner organizations.

Donate Now
CIFAR header logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2025 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more